Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125541631 | 12554163 | 1 | I | 201601 | 20160520 | 20160713 | 20160713 | EXP | BR-ELI_LILLY_AND_COMPANY-BR201605007642 | ELI LILLY AND CO | 78.20 | YR | F | Y | 0.00000 | 20160713 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125541631 | 12554163 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | UNK, UNKNOWN | U | U | C467328 | 21427 | 60 | MG | CAPSULE | QD | |||
| 125541631 | 12554163 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | U | U | 21427 | CAPSULE | |||||||||
| 125541631 | 12554163 | 3 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | U | U | 21427 | CAPSULE | |||||||||
| 125541631 | 12554163 | 4 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Unknown | 50 MG, UNKNOWN | 0 | 50 | MG | ||||||||
| 125541631 | 12554163 | 5 | C | VALSARTAN. | VALSARTAN | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 125541631 | 12554163 | 6 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 125541631 | 12554163 | 7 | C | BETASERC /00141801/ | BETAHISTINE | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 125541631 | 12554163 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 125541631 | 12554163 | 9 | C | AAS PROTECT | ASPIRIN | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 125541631 | 12554163 | 10 | C | EXFORGE HCT | AMLODIPINE BESYLATEHYDROCHLOROTHIAZIDEVALSARTAN | 1 | Unknown | UNK, UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125541631 | 12554163 | 1 | Nervous system disorder |
| 125541631 | 12554163 | 2 | Stress |
| 125541631 | 12554163 | 3 | Depressed mood |
| 125541631 | 12554163 | 4 | Diabetes mellitus |
| 125541631 | 12554163 | 5 | Hypertension |
| 125541631 | 12554163 | 6 | Carotid artery disease |
| 125541631 | 12554163 | 7 | Labyrinthitis |
| 125541631 | 12554163 | 8 | Carotid artery disease |
| 125541631 | 12554163 | 9 | Anticoagulant therapy |
| 125541631 | 12554163 | 10 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125541631 | 12554163 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125541631 | 12554163 | Agitation | |
| 125541631 | 12554163 | Anxiety | |
| 125541631 | 12554163 | Blood glucose fluctuation | |
| 125541631 | 12554163 | Carotid artery disease | |
| 125541631 | 12554163 | Carotid artery occlusion | |
| 125541631 | 12554163 | Hypersensitivity | |
| 125541631 | 12554163 | Nervousness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |